Teva Pharmaceutical Industries Ltd ADR Stock
Teva Pharmaceutical Industries Ltd ADR gained 0.350% compared to yesterday.
The stock is an absolute favorite of our community with 23 Buy predictions and no Sell predictions.
As a result the target price of 31 € shows a slightly positive potential of 7.27% compared to the current price of 28.9 € for Teva Pharmaceutical Industries Ltd ADR.
For the coming years our community has positive and negative things to say abot the Teva Pharmaceutical Industries Ltd ADR stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Conscious of the environment" there were negative voices in the community.
Pros and Cons of Teva Pharmaceutical Industries Ltd ADR in the next few years
Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Teva Pharmaceutical Industries Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 0.350% | 0.699% | 6.667% | 79.439% | 7.063% | 205.085% | 230.275% |
| Bayer AG ADR | -0.950% | -10.656% | 0.926% | 92.920% | 23.864% | -25.342% | -18.657% |
| UCB S.A. | -1.290% | -3.383% | 5.318% | 50.055% | 14.280% | 236.350% | 239.549% |
| Novartis AG ADR | 1.430% | 1.083% | 12.450% | 33.333% | 18.143% | 71.569% | 95.804% |
Comments
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Truist Financial Corporation from $38.00 to $42.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $36.00 to $45.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Barclays PLC from $35.00 to $38.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TEVA provided by MarketBeat